OTC Markets OTCPK - Delayed Quote • USD
Bellerophon Therapeutics, Inc. (BLPH)
At close: 12:51 PM EDT
Breakdown
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Operating Cash Flow
-12,339.0000
-17,770.0000
-22,821.0000
-19,884.0000
-12,936.0000
Financing Cash Flow
4,968.0000
-40.0000
--
57,567.0000
6,167.0000
End Cash Position
4,490.0000
7,329.0000
25,139.0000
47,960.0000
10,277.0000
Issuance of Capital Stock
1,437.0000
--
--
54,696.0000
6,236.0000
Free Cash Flow
-12,339.0000
-17,770.0000
-22,821.0000
-19,884.0000
-12,936.0000
12/31/2019 - 2/13/2015
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
PULM Pulmatrix, Inc.
1.8300
-5.67%
BNTC Benitec Biopharma Inc.
8.55
-7.07%
LIANY LianBio
0.3137
-5.51%
XBIO Xenetic Biosciences, Inc.
3.8200
-4.50%
SQZB SQZ Biotechnologies Company
0.0250
-1.96%
FRTX Fresh Tracks Therapeutics, Inc.
0.8601
-4.45%
NBSE NeuBase Therapeutics, Inc.
0.3780
-1.56%
CAPR Capricor Therapeutics, Inc.
6.10
+1.84%
MBRX Moleculin Biotech, Inc.
4.5800
-6.91%
HMTXF Hemostemix Inc.
0.0338
+12.67%